Multiple Ascending Dose Study of HM12470 in Type 1 and Type 2 Diabetes Mellitus

PK/PD Study of Gan & Lee's Insulin Glargine Injection in Comparison to Lantus in Type 1 Diabetes

NCT02506647 ·Status: COMPLETED ·Phase: PHASE1

Safety and Efficacy of Inhaled Pre-prandial Human Insulin in Type 2 Diabetes

NCT00343980 ·Status: TERMINATED ·Phase: PHASE3

Evaluation of the Safety and Efficacy of Insulin Glargine 300 U/ml (Gla-300) in Insulin-naïve Patients With Type 2 Diabetes Mellitus Uncontrolled on Oral Antihyperglycemic Drugs

NCT04980027 ·Status: COMPLETED ·Phase: PHASE4

Comparison of a New Formulation of Insulin Glargine With Lantus® in Japanese Patients With Type 1 Diabetes Mellitus

NCT01689129 ·Status: COMPLETED ·Phase: PHASE3

A Research Study of How Different Amounts of a New Medicine NNC0148-0287 C (Insulin 287) Works on the Blood Sugar of People Who Are Japanese With Type 1 Diabetes When Given Once a Week

NCT03766854 ·Status: COMPLETED ·Phase: PHASE1

Efficacy and Safety of Inhaled Insulin Compared to Metformin and Glimepiride in Type 2 Diabetes

NCT00469586 ·Status: TERMINATED ·Phase: PHASE3

Chronic Reduction of Fasting Glycaemia With Insulin Glargine Improves First and Second Phase Insulin Secretion in Patients With Type 2 Diabetes

NCT01249677 ·Status: COMPLETED ·Phase: PHASE4

Insulin Glargine Benefits in Japanese Pts Outside of Japan (US or Brazil)

NCT00642915 ·Status: COMPLETED ·Phase: PHASE4

Single Dose Clamp Study To Compare Concentration/Time Profile And Metabolic Activity Profile Of 2 New Formulations Of Insulin Glargine With Lantus

NCT02201199 ·Status: COMPLETED ·Phase: PHASE1

Glulisine + Lantus in Type I Patients

NCT00546702 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Inhaled Pre-prandial Human Insulin in Type 2 Diabetes

NCT00348712 ·Status: TERMINATED ·Phase: PHASE3

Insulin Glargine in Type 2 Diabetic Patients

NCT00347100 ·Status: COMPLETED ·Phase: PHASE4

Intensive Insulin Glulisine Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Basal Insulin and Oral Glucose-lowering Drugs

NCT01203111 ·Status: COMPLETED ·Phase: PHASE4

Glulisine + Lantus in Type I Patients

NCT00545337 ·Status: COMPLETED ·Phase: PHASE3

Human Versus Analogue Insulin for Youth With Type 1 Diabetes in Low-Resource Settings

NCT05614089 ·Status: COMPLETED ·Phase: PHASE4

Dose-Ranging, Pharmacokinetic (PK), Glucodynamic (GD), Safety and Tolerability Study of Subcutaneously (SC) Administered Humulin R and Humalog With or Without rHuPH20

NCT00803972 ·Status: COMPLETED ·Phase: PHASE1

Trial to Compare NNC0123-0000-0338 in a Tablet Formulation and Insulin Glargine in Subjects With Type 2 Diabetes Currently Treated With Oral Antidiabetic Therapy

NCT02470039 ·Status: COMPLETED ·Phase: PHASE2

Gulf, Lantus, Apidra Evaluation in Type 1 Diabetics Study

NCT00539448 ·Status: COMPLETED ·Phase: PHASE4

Insulin Glulisine, Insulin Lispro and Insulin Glargine in Type 1 or 2 Diabetes Mellitus

NCT00467376 ·Status: COMPLETED ·Phase: PHASE3

A Trial Investigating the Effect of NN1250 in Japanese Subjects With Type 1 Diabetes

NCT01135927 ·Status: COMPLETED ·Phase: PHASE1

Insulin Glargine Plus Insulin Glulisine Multiple Daily Injections (MDI) Versus Premix Insulin Treatment in Subjects With Diabetes Mellitus (Type 1 or Type 2)

NCT00135941 ·Status: COMPLETED ·Phase: PHASE3

A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Insulin 320 in Healthy Subjects

NCT02479022 ·Status: COMPLETED ·Phase: PHASE1

Insulins Glargine and gluLisine strAtegy Versus Premixed Insulin strAteGy: a cOmparative Study

NCT01121835 ·Status: COMPLETED ·Phase: PHASE4

Insulin Glargine Injection Treatment in Place of Thiazolidinedione (TZD), Sulfonylurea, or Metformin in Triple Agent Therapy for Type 2 Diabetes Mellitus (T2DM) Adult Subjects With Unsatisfactory Control

NCT00283049 ·Status: TERMINATED ·Phase: PHASE4

Evaluation of the Effects of Different Interventions on Glycemic Control in Newly-Diagnosed Type 2 Diabetic Patients

NCT00147836 ·Status: COMPLETED ·Phase: NA